These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 5363890

  • 1. [On the results of treatment and complications during the use of haloperidol in patients with long-term schizophrenia].
    Zolotnitskii RI, Kutsenok BM, Gastev MD.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(5):750-4. PubMed ID: 5363890
    [No Abstract] [Full Text] [Related]

  • 2. A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism.
    Ekdawi MY, Fowke R.
    Br J Psychiatry; 1966 Jun; 112(487):633-6. PubMed ID: 5964267
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Sensory disorders arising during neuroleptic therapy].
    Rovinskaia SA, Revva LI.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980 Jun; 80(6):905-9. PubMed ID: 6106339
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms].
    Lejoyeux M, Gorwood P, Stalla-Bourdillon A, Adès J.
    Encephale; 1993 Jun; 19(1):17-21. PubMed ID: 8275889
    [Abstract] [Full Text] [Related]

  • 9. [Sudden cessation of psychotropic drugs].
    Avrutskii GIa, Gurovich IIa, Prokhorova IS, Tirkel'taub IuA, Romanov IuD.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974 Jun; 74(6):923-30. PubMed ID: 4156142
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparison of haloperidol and thioridazine HC1 in chronic treatment-resistant schizophrenics.
    Gonier T, Schiele BC, Vestre ND.
    Behav Neuropsychiatry; 1970 Jun; 2(3):47-9 passim. PubMed ID: 4913152
    [No Abstract] [Full Text] [Related]

  • 14. Haloperidol in overt ambulatory schizophrenics.
    Darling HF.
    Dis Nerv Syst; 1973 Jun; 34(7):364-7. PubMed ID: 4782293
    [No Abstract] [Full Text] [Related]

  • 15. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
    Greger J, Glitschka A, Müller K.
    Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
    [No Abstract] [Full Text] [Related]

  • 16. [Somatic disorders during long-term drug treatment of schizophrenic patients].
    vom Brocke I.
    Internist (Berl); 1974 May; 15(5):268-70. PubMed ID: 4213663
    [No Abstract] [Full Text] [Related]

  • 17. [Use of triphthazine in the treatment of mentae disorders].
    Gurowitsch IJ, Awruzki GJ.
    Psychiatr Neurol Med Psychol (Leipz); 1975 May; 27(5):284-91. PubMed ID: 812131
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
    Kane JM, Lauriello J, Laska E, Di Marino M, Wolfgang CD.
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.